Navigation Links
CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors
Date:10/8/2009

PALO ALTO, Calif., Oct. 8 /PRNewswire/ -- CardioDx, a cardiovascular genomic diagnostics company, announced today the appointment of Louis G. Lange, M.D., Ph.D., as Chairman of the company's Board of Directors. CardioDx recently launched Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(1) coronary artery disease (CAD) in patients with stable chest pain.

"Dr. Lange brings an ideal perspective to CardioDx as both a cardiologist and businessman who co-founded and cultivated a successful cardiovascular business," said David Levison, chief executive officer of CardioDx. "His clinical cardiology expertise, commercialization experience and firsthand understanding of diagnostics will serve as a great resource for the company as more physicians integrate Corus CAD into their daily practice."

Dr. Lange has over 20 years' experience in medicine at Harvard University and Washington University, where he served as Chief of Cardiology and Professor of Medicine at Jewish Hospital and was one of the first academicians in molecular cardiology. Most recently, Dr. Lange founded CV Therapeutics, Inc., where he served as Chairman and CEO from 1992 to 2009, overseeing the successful commercialization of a product portfolio solely focused on cardiovascular health. Dr. Lange led the company's success through its sale in 2009 to Gilead for $1.4B. Dr. Lange also sits on the boards of Maxygen, Metabolex and Synecor.

"I'm excited to join the Board of Directors of CardioDx as Chairman to help broaden adoption of Corus CAD, a groundbreaking blood-based test that helps office-based physicians more effectively assess obstructive CAD before more invasive testing may be necessary," said Dr. Lange. "I believe that Corus CAD signals the emergence of a new era in convenient and safe cardiovascular genomic diagnostics and will be of great use to all physicians who see chest pain patients on a daily basis."


'/>"/>
SOURCE CardioDx
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. IridoTech Announces IridoLab Self Service Kiosk
2. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
3. NCIIA Announces New Undergraduate Competition
4. Sangamo Announces Pricing of Public Offering of Common Stock
5. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
6. Verenium Announces Proposed Public Offering of Common Stock
7. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
8. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
9. ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
10. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
11. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... Preclinical-Stage Compounds ... in Merck KGaA Pipeline, ... discovery and development company, announced today that,it will collaborate with ... new applications for drug candidates. KineMed,s,proprietary pathway-based drug discovery and ...
... YORK, August 28 XTL Biopharmaceuticals,Ltd. (NASDAQ: ... company,engaged in the acquisition, development and commercialization of,therapeutics ... pain and hepatitis C, today announced that issuances ... depositary bank,The Bank of New York, will be ...
... ... FY2007 Annual Targets Under Review, BEIJING, Aug. 28 ... CMED ), a leading China-based,medical device company that develops, ... intensity focused ultrasound tumor,therapy system, today announced its unaudited ...
Cached Biology Technology:KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates 2Processing Fees on ADRs to be Waived for two Months 2Processing Fees on ADRs to be Waived for two Months 3China Medical Technologies Reports First Quarter Financial Results 2China Medical Technologies Reports First Quarter Financial Results 3China Medical Technologies Reports First Quarter Financial Results 4China Medical Technologies Reports First Quarter Financial Results 5China Medical Technologies Reports First Quarter Financial Results 6China Medical Technologies Reports First Quarter Financial Results 7China Medical Technologies Reports First Quarter Financial Results 8China Medical Technologies Reports First Quarter Financial Results 9China Medical Technologies Reports First Quarter Financial Results 10China Medical Technologies Reports First Quarter Financial Results 11China Medical Technologies Reports First Quarter Financial Results 12China Medical Technologies Reports First Quarter Financial Results 13China Medical Technologies Reports First Quarter Financial Results 14
(Date:12/22/2014)... SHELTON, Conn. , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile commerce ... consultant, Apollo Robbins for the 2015 International CES ... Apollo Robbins will be at the NXT-ID booth ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics company, today ... in genetic ancestry of individuals from across the ... more than four hundred years ago, the United ... peoples from different continents. This study illuminates how American history ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader ... PerformTek biometric technology to industry leaders such as Intel, ... clinically validated, biometric wearable products. These products will be ... Las Vegas . ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... DURHAM, N.H. A team of chemists from ... stable derivative of nonacene, creating a compound that holds ... such as large displays, solar cells and radio frequency ... chemistry and materials science Glen Miller and including two ...
... (Feb. 11, 2010) For years, doctors have warned patients ... by a "superbug" that can mount a more powerful defense ... University biomedical engineers indicates that treating bacteria with levels of ... to a wide range of antibiotics. In the Feb. ...
... at Queen,s University suggest that policy makers examine ... as fossil fuel sources must be rapidly replaced ... renewable energy., Their recommendations could be used to ... a way that will optimize greenhouse gas emission ...
Cached Biology News:UNH chemists create molecule with promising semiconductor properties 2Low levels of antibiotics cause multidrug resistance in 'superbugs' 2Low levels of antibiotics cause multidrug resistance in 'superbugs' 3Queen's researchers propose rethinking renewable energy strategy 2
... The GeneSwitch Cell Lines stably ... pSwitch. Each cell line is functionally ... transfection with the expression control vector ... expression after treatment with mifepristone (Figure ...
... OrientExpress™ System Modules ... and directional cloning into ... expression vectors ... OrientExpress™ Cloning Systems, the ...
... CHEMICON Re-Blot Western Blot Recycling Kit ... from Western blots that have been ... or other isotopes. It is not ... DAB, 4-chloronapthol, etc.), as it is ...
Applications: Western blotting ...
Biology Products: